Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers

NCT02268604 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIIB 722 CL
DRUG: Placebo

Sponsor

Boehringer Ingelheim